Inactive Instrument

GI Dynamics, Inc. Stock price Australian S.E.

Equities

GID

AU000000GID7

Sales 2019 - Sales 2020 - Capitalization 440K 676K
Net income 2019 -17M -26.09M Net income 2020 -11M -16.88M EV / Sales 2019 -
Net Debt 2019 2.89M 4.43M Net Debt 2020 2.84M 4.36M EV / Sales 2020 -
P/E ratio 2019
-1.12 x
P/E ratio 2020
-0.03 x
Employees -
Yield 2019 *
-
Yield 2020
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 20-10-07
Chief Tech/Sci/R&D Officer 67 19-01-03
Treasurer - -
Members of the board TitleAgeSince
Chairman 65 20-08-09
Chief Executive Officer - 20-10-07
Director/Board Member - 20-10-19
More insiders
GI Dynamics, Inc. is a medical device company. The Company designs and applies device and disease management solutions for the treatment of metabolic disease. The Company designs, develops, manufactures and markets medical devices for non-surgical approaches to treat type II diabetes and obesity. The Company's product, EndoBarrier, is an endoscopically-delivered device therapy, which is approved for the treatment of obese type II diabetes with body mass index (BMI) greater than or equal to 30 kilogram/square meter (kg/m2), or obese patients with BMI greater than or equal to 30 kg/m2 with greater than or equal to one comorbidities, or obese patients with BMI over 35 kg/m2. EndoBarrier is an incision-free, non-anatomy altering solution designed to specifically mimic the duodenal-jejunal exclusion created by gastric bypass surgery.
Sector
-
More about the company
  1. Stock
  2. Equities
  3. Stock GI Dynamics, Inc.
  4. Stock GI Dynamics, Inc. - Australian S.E.